Cargando…

Glycolytic Metabolic Remodeling by the Truncate of Glioma-Associated Oncogene Homolog 1 in Triple-Negative Breast Cancer Cells

Hedgehog (Hh) signaling pathway plays an essential role in embryonic development, tissue regeneration, and stem cell renewal. In particular, terminal effectors of the Hh signaling pathway are associated with the regulation of glioma-associated oncogene homolog 1 (GLI1) transcription factors. Overexp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Su Hyun, Lee, Ji Sun, Park, Jae Hyeon, Yoon, Sungpil, Lee, Kwang Youl, Kim, Hyung Sik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414023/ https://www.ncbi.nlm.nih.gov/pubmed/36046646 http://dx.doi.org/10.7150/jca.72793

Ejemplares similares

Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis
por: Jo, Min-Sik, et al.
Publicado: (2023)

JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells
por: Oh, Yunmoon, et al.
Publicado: (2022)

Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity
por: Lee, Ji Sun, et al.
Publicado: (2022)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
por: Peterlongo, Paolo, et al.
Publicado: (2021)

WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma
por: Chen, Shuai, et al.
Publicado: (2018)

Prognostic Value of a Glycolytic Signature and Its Regulation by Y-Box-Binding Protein 1 in Triple-Negative Breast Cancer
por: Lai, Yi-Wen, et al.
Publicado: (2021)

Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity
por: Lee, Ji Sun, et al.
Publicado: (2022)

Contribution of Cancer-Targeting Drugs toward Faster Clinical Application
por: Yoon, Sungpil, et al.
Publicado: (2022)

First-Line Combination Treatment with Low-Dose Bipolar Drugs for ABCB1-Overexpressing Drug-Resistant Cancer Populations
por: Yoon, Sungpil, et al.
Publicado: (2023)

Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cells
por: Reda, Asmaa, et al.
Publicado: (2019)

The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
por: Reuss, Anna Maria, et al.
Publicado: (2021)

Truncating mutation in the autophagy gene UVRAG confers oncogenic properties and chemosensitivity in colorectal cancers
por: He, Shanshan, et al.
Publicado: (2015)

Glioma-Associated Oncogene Homolog1 (Gli1)-Aquaporin1 pathway promotes glioma cell metastasis
por: Liao, Zheng-qiang, et al.
Publicado: (2016)

Intersection spaces, spatial homology truncation, and string theory
por: Banagl, Markus
Publicado: (2010)

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
por: Figlioli, Gisella, et al.
Publicado: (2019)

Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial Tumors
por: Lee, Minyi, et al.
Publicado: (2020)

Prognostic Value of Erythroblastic Leukemia Viral Oncogene Homolog 2 and Neuregulin 4 in Hepatocellular Carcinoma
por: Rou, Woo Sun, et al.
Publicado: (2023)

Low-Dose Crizotinib, a Tyrosine Kinase Inhibitor, Highly and Specifically Sensitizes P-Glycoprotein-Overexpressing Chemoresistant Cancer Cells Through Induction of Late Apoptosis in vivo and in vitro
por: Kim, Kyeong Seok, et al.
Publicado: (2020)

Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer
por: Dowling, Catríona M., et al.
Publicado: (2021)

Silencing glioma-associated oncogene homolog 1 suppresses the migration and invasion of hepatocellular carcinoma in vitro
por: Hu, Zeming, et al.
Publicado: (2020)

Expression of Glioma-associated oncogene homolog 1 as biomarker with sonidegib in advanced basal cell carcinoma
por: Dummer, Reinhard, et al.
Publicado: (2020)

The potential of glioma-associated oncogene homolog 1 (GLI1) as a therapeutic target in endometriosis
por: Nirgianakis, Konstantinos, et al.
Publicado: (2020)

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
por: Zingg, Daniel, et al.
Publicado: (2022)

Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer
por: Sánchez-Muñoz, Alfonso, et al.
Publicado: (2010)

Ferroptosis: the emerging player in remodeling triple-negative breast cancer
por: Li, Jie, et al.
Publicado: (2023)

Expression of Glioma-associated Oncogene Homolog 1 is Associated with Invasion and Postoperative Liver Metastasis in Colon Cancer
por: Ding, Yin-lu, et al.
Publicado: (2012)

Glioma-Associated Oncogene Homolog Inhibitors Have the Potential of Suppressing Cancer Stem Cells of Breast Cancer
por: Jeng, Kuo-Shyang, et al.
Publicado: (2018)

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
por: Fang, Wentong, et al.
Publicado: (2021)

Early‐onset triple‐negative breast cancer in multiracial/ethnic populations: Distinct trends of prevalence of truncation mutations
por: Liu, Qian, et al.
Publicado: (2019)

Super-enhancer acquisition drives oncogene expression in triple negative breast cancer
por: Raisner, Ryan, et al.
Publicado: (2020)

Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses
por: Xiao, Xiao, et al.
Publicado: (2021)

The Oncogene MYCN Modulates Glycolytic and Invasive Genes to Enhance Cell Viability and Migration in Human Retinoblastoma
por: Sradhanjali, Swatishree, et al.
Publicado: (2021)

Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival
por: ten Haaf, Anette, et al.
Publicado: (2009)

The Human Glioma-Associated Oncogene Homolog 1 (GLI1) Family of Transcription Factors in Gene Regulation and Diseases
por: Zhu, Hu, et al.
Publicado: (2010)

Critical role of glioma‐associated oncogene homolog 1 in maintaining invasive and mesenchymal‐like properties of melanoma cells
por: Gunarta, I Ketut, et al.
Publicado: (2017)

Molecular Mechanism of SAHA on Regulation of Autophagic Cell Death in Tamoxifen-Resistant MCF-7 Breast Cancer Cells
por: Lee, Young Ju, et al.
Publicado: (2012)

Biological Evaluation of Oxindole Derivative as a Novel Anticancer Agent against Human Kidney Carcinoma Cells
por: Dey, Prasanta, et al.
Publicado: (2020)

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
por: Zingg, Daniel, et al.
Publicado: (2022)

Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
por: Zurlo, Giada, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eovhghb1i3g37mi6soups2n7k3